Mobile Cognitive Behavioral Therapy for Stroke
Part of paid clinical trials in New York, New York.
- Sponsor
- Weill Medical College of Cornell University
- Study ID
- NCT06689878
- Status
- Recruiting
Conditions
- Anxiety
- Depression
- Stroke
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - 79 Years
- Healthy Volunteers
- Not accepted
Interventions
- Mobile Cognitive Behavioral App — BEHAVIORALA mobile cognitive behavioral therapy (CBT) app called "Maya" that includes modules with educational content and teaching and practice of strategies that address depression and anxiety after stroke.
Study Details
This study aims to assess the feasibility and acceptability of "MAYA", a mobile cognitive behavioral therapy app for anxiety and mood disorders, in adults who have had a stroke.
Key Dates
- Start date
- Feb 25, 2025
- Status verified
- Mar 2026
- Primary completion
- Mar 31, 2028
- Completion
- Mar 31, 2028
Study Design
- Enrollment
- 10 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Intervention Arm Using the Mobile Cognitive Behavioral Therapy AppAll participants will receive the same intervention arm, a mobile cognitive behavioral therapy (CBT) app that includes modules with educational content and teaching and practice of strategies that address the following: education about anxiety and depression and their association with stroke recovery; awareness and monitoring of emotions; behavioral activation, i.e., increasing engagement in valued and meaningful activities; increasing awareness of thinking errors and reframing negative thoughts; mindfulness; relaxation skills; increasing tolerance of anxiety in anxiety-provoking situations; and problem-solving. The application includes an interactive dashboard to provide the user with statistics for tracking progress toward their goals. Participants will be asked to use the application for 30 minutes per day, 2 days per week, for 8 weeks.
Primary Outcome Measure
Feasibility and Acceptability of MAYA as measured by the Mobile Application Rating Scale-User Version (uMARS) [ Time Frame: Week 4 of treatment ]
Central Contacts
- Abhishek Jaywant, PhD212-746-4666
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Weill Cornell Medicine | New York | New York | 10065 | Abhishek Jaywant, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in New York, NY
By condition
By research site
Related Studies
- Genetic and Environmental Risk Factors for Hemorrhagic StrokeRecruiting · State University of New York at Buffalo · Chicago, Illinois
- GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyRecruiting · W.L.Gore & Associates · Tucson, Arizona
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPHASE3 · Recruiting · Icahn School of Medicine at Mount Sinai · Little Rock, Arkansas
- Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic AphasiaRecruiting · City University of New York · New York, New York